CRISPR Therapeutics Vertex Pharmaceuticals: Better Buy in 2026
Investors face a choice between a high-growth gene-editing bet and a cash-generating biotech leader. This article bre...
Compare credit cards to find the one with the best rewards program. Make an informed choice and maximize your benefits.
27,943 articlesInvestors face a choice between a high-growth gene-editing bet and a cash-generating biotech leader. This article bre...
Bastion Asset Management just revealed a new stake in Parsons, signaling confidence in steady government spending on ...
Analysts warn that social security faces insolvency by 2032, threatening to reduce guaranteed benefits for 70 million...
Greg Abel, two months into his role as Berkshire Hathaway CEO, commits to using his after-tax salary to buy Berkshire...
BuildersUpdate launched a pay-on-performance marketing model, charging a $750 fee per home only when a sale closes, a...
Investors are focused on ducommun (dco) 2026 earnings as Q1 sets the tone for the year. This article explains how to ...
A 54-year-old former corporate worker considers a welding certificate in shipbuilding after a layoff. The move could ...
Instagram will notify parents in its supervision program when their teens search suicide- or self-harm-related terms,...
Boeing’s stock is drawing fresh attention as defense-focused equities outperform, underpinned by a robust backlog and...
Rheinmetall posted a quarterly miss that undercut expectations for revenue, net income and margins, triggering a pull...
As the Social Security Retirement Trust Fund nears insolvency, lawmakers debate a six-figure cap on benefits for high...
A biotech name drops sharply after mixed obesity data, sending Wave Life Sciences and the broader market into a brief...